Trial intelligence / Profile preview

Vitamin D Supplementation and Calcium Excretion in Thalassemia Major

NCT01323608Phase 4Unknown

Sponsor
Weill Cornell Medicine
Start
Jun 2011
Primary completion
Jun 2014
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) and osteoporosis, sponsored by Weill Cornell Medicine. Status: unknown.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)osteoporosis

Beyond the preview

Go deeper on NCT01323608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01323608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call